7-30628621-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP7
The NM_002047.4(GARS1):c.1761G>C(p.Thr587Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 32)
Consequence
GARS1
NM_002047.4 synonymous
NM_002047.4 synonymous
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.18
Genes affected
GARS1 (HGNC:4162): (glycyl-tRNA synthetase 1) This gene encodes glycyl-tRNA synthetase, one of the aminoacyl-tRNA synthetases that charge tRNAs with their cognate amino acids. The encoded enzyme is an (alpha)2 dimer which belongs to the class II family of tRNA synthetases. It has been shown to be a target of autoantibodies in the human autoimmune diseases, polymyositis or dermatomyositis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP7
Synonymous conserved (PhyloP=-2.18 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GARS1 | NM_002047.4 | c.1761G>C | p.Thr587Thr | synonymous_variant | 14/17 | ENST00000389266.8 | NP_002038.2 | |
GARS1 | NM_001316772.1 | c.1599G>C | p.Thr533Thr | synonymous_variant | 14/17 | NP_001303701.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GARS1 | ENST00000389266.8 | c.1761G>C | p.Thr587Thr | synonymous_variant | 14/17 | 1 | NM_002047.4 | ENSP00000373918.3 | ||
GARS1 | ENST00000675651.1 | c.1761G>C | p.Thr587Thr | synonymous_variant | 14/17 | ENSP00000502513.1 | ||||
GARS1 | ENST00000675810.1 | c.1659G>C | p.Thr553Thr | synonymous_variant | 13/16 | ENSP00000502743.1 | ||||
GARS1 | ENST00000675693.1 | c.1593G>C | p.Thr531Thr | synonymous_variant | 15/18 | ENSP00000502174.1 | ||||
GARS1 | ENST00000675051.1 | c.1560G>C | p.Thr520Thr | synonymous_variant | 14/17 | ENSP00000502296.1 | ||||
GARS1 | ENST00000674815.1 | c.1392G>C | p.Thr464Thr | synonymous_variant | 14/17 | ENSP00000502799.1 | ||||
GARS1 | ENST00000674851.1 | c.1392G>C | p.Thr464Thr | synonymous_variant | 15/18 | ENSP00000502451.1 | ||||
GARS1 | ENST00000444666.6 | n.*182G>C | non_coding_transcript_exon_variant | 15/18 | 3 | ENSP00000415447.2 | ||||
GARS1 | ENST00000674616.1 | n.*1475G>C | non_coding_transcript_exon_variant | 15/18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000674643.1 | n.*861G>C | non_coding_transcript_exon_variant | 15/17 | ENSP00000501636.1 | |||||
GARS1 | ENST00000674737.1 | n.*1099G>C | non_coding_transcript_exon_variant | 15/18 | ENSP00000502464.1 | |||||
GARS1 | ENST00000674807.1 | n.*34G>C | non_coding_transcript_exon_variant | 13/16 | ENSP00000502814.1 | |||||
GARS1 | ENST00000675529.1 | n.*1631G>C | non_coding_transcript_exon_variant | 15/18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000675859.1 | n.*34G>C | non_coding_transcript_exon_variant | 13/15 | ENSP00000502033.1 | |||||
GARS1 | ENST00000676088.1 | n.*1703G>C | non_coding_transcript_exon_variant | 16/19 | ENSP00000501884.1 | |||||
GARS1 | ENST00000676140.1 | n.*706G>C | non_coding_transcript_exon_variant | 14/17 | ENSP00000502571.1 | |||||
GARS1 | ENST00000676164.1 | n.*1212G>C | non_coding_transcript_exon_variant | 14/17 | ENSP00000501986.1 | |||||
GARS1 | ENST00000676210.1 | n.*1050G>C | non_coding_transcript_exon_variant | 15/18 | ENSP00000502373.1 | |||||
GARS1 | ENST00000676259.1 | n.*1193G>C | non_coding_transcript_exon_variant | 14/17 | ENSP00000501980.1 | |||||
GARS1 | ENST00000676403.1 | n.1761G>C | non_coding_transcript_exon_variant | 14/16 | ENSP00000502681.1 | |||||
GARS1 | ENST00000444666.6 | n.*182G>C | 3_prime_UTR_variant | 15/18 | 3 | ENSP00000415447.2 | ||||
GARS1 | ENST00000674616.1 | n.*1475G>C | 3_prime_UTR_variant | 15/18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000674643.1 | n.*861G>C | 3_prime_UTR_variant | 15/17 | ENSP00000501636.1 | |||||
GARS1 | ENST00000674737.1 | n.*1099G>C | 3_prime_UTR_variant | 15/18 | ENSP00000502464.1 | |||||
GARS1 | ENST00000674807.1 | n.*34G>C | 3_prime_UTR_variant | 13/16 | ENSP00000502814.1 | |||||
GARS1 | ENST00000675529.1 | n.*1631G>C | 3_prime_UTR_variant | 15/18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000675859.1 | n.*34G>C | 3_prime_UTR_variant | 13/15 | ENSP00000502033.1 | |||||
GARS1 | ENST00000676088.1 | n.*1703G>C | 3_prime_UTR_variant | 16/19 | ENSP00000501884.1 | |||||
GARS1 | ENST00000676140.1 | n.*706G>C | 3_prime_UTR_variant | 14/17 | ENSP00000502571.1 | |||||
GARS1 | ENST00000676164.1 | n.*1212G>C | 3_prime_UTR_variant | 14/17 | ENSP00000501986.1 | |||||
GARS1 | ENST00000676210.1 | n.*1050G>C | 3_prime_UTR_variant | 15/18 | ENSP00000502373.1 | |||||
GARS1 | ENST00000676259.1 | n.*1193G>C | 3_prime_UTR_variant | 14/17 | ENSP00000501980.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 30
GnomAD4 exome
Cov.:
30
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.